Deferoxamine reduces early brain injury following subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn , Issue 112, 2011, Pages 101-106

  Lee, Jin Yul ^a   Keep, Richard F ^b   Hua, Ya ^b   Ernestus, Ralf Ingo ^a   Xi, Guohua ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Deferoxamine; Hemoglobin; Iron; Neuronal death; Subarachnoid hemorrhage

Indexed keywords

DEFEROXAMINE; FERRITIN; HEME OXYGENASE 1; NONHEME IRON PROTEIN; IRON; SIDEROPHORE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INJURY; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FERRITIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INTRACRANIAL PRESSURE MONITORING; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN; DISEASE MODEL; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; MORTALITY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN INJURIES; DEFEROXAMINE; DISEASE MODELS, ANIMAL; DNA DAMAGE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; IN SITU NICK-END LABELING; IRON; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIDEROPHORES; SUBARACHNOID HEMORRHAGE;

EID: 79960670456     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0661-7_18     Document Type: Conference Paper

References (12)

1. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A (1994) Initial and recurrent bleeding are the major causes of death follow-ing subarachnoid hemorrhage. Stroke 25:1342-1347 (Pubitemid 24198577)
2. Carbonell T, Rama R (2007) Iron, oxidative stress and early neuro-logical deterioration in ischemic stroke. Curr Med Chem 14:857-874 (Pubitemid 46863616)
3. Chen K, Jin K, Chen M, Pei W, Kawaguchi K, Greenberg DA, Simon RP (1997) Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA dam-age in apoptosis and neuronal cell death. J Neurochem 69:232-245 (Pubitemid 27274177)
4. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G (2006) Long-term effects of experimental intracerebral hemor-rhage: the role of iron. J Neurosurg 104:305-312
5. Koeppen AH, Dickson AC, McEvoy JA (1995) The cellular reac-tions to experimental intracerebral hemorrhage. J Neurol Sci 134: 102-112
6. Lee J-Y, Sagher O, Keep R, Hua Y, Xi G (2009) Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery 65:331-343
7. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G (2004) Deferoxamine-induced attenuation of brain edema and neurological defcits in a rat model of intracerebral hemorrhage. J Neurosurg 100:672-678 (Pubitemid 38372849)
8. Nina P, Schisano G, Chiappetta F, Luisa Papa M, Maddaloni E, Brunori A, Capasso F, Corpetti MG, Demurtas F (2001) A study of blood coagulation and fbrinolytic system in spontaneous subarach-noid hemorrhage. Correlation with Hunt-Hess grade and outcome. Surg Neurol 55:197-203 (Pubitemid 32453178)
9. Palmer C, Roberts RL, Bero C (1994) Deferoxamine posttreat-ment reduces ischemic brain injury in neonatal rats. Stroke 25: 1039-1045 (Pubitemid 24130313)
10. Song S, Hua Y, Keep RF, Hoff JT, Xi G (2007) A new hippocampal model for examining intracerebral hemorrhage-related neuronal death. Stroke 38:2861-2863
11. Syapin PJ (2009) Regulation of haeme oxygenase-1 for treatment of neuroinfammation and brain disorders. Br J Pharmacol 155:623-640
12. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF (2003) Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629-652 (Pubitemid 36713668)